Key Financial Data Of Group

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7315166

Concept 2024-01-01 to
2024-06-30
As at
2024-06-30
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-06-30
As at
2023-06-30
Key financial data of group
Business results of group
Revenue
552,860,000,000 JPY
1,111,367,000,000 JPY
579,657,000,000 JPY
Profit (loss) before tax
258,690,000,000 JPY
443,821,000,000 JPY
213,656,000,000 JPY
Profit (loss)
186,262,000,000 JPY
325,472,000,000 JPY
156,693,000,000 JPY
Profit (loss), attributable to owners of parent
186,262,000,000 JPY
325,472,000,000 JPY
156,693,000,000 JPY
Comprehensive income
191,645,000,000 JPY
332,256,000,000 JPY
154,432,000,000 JPY
Comprehensive income, attributable to owners of parent
191,645,000,000 JPY
332,256,000,000 JPY
154,432,000,000 JPY
Total assets
2,060,163,000,000 JPY
1,932,547,000,000 JPY
1,831,590,000,000 JPY
Basic earnings (loss) per share
113.20
197.83
95.25
Diluted earnings (loss) per share
113.19
197.80
95.23
Ratio of owners' equity to gross assets
0.850 xbrli:pure
0.841 xbrli:pure
0.826 xbrli:pure
Cash flows from (used in) operating activities
171,563,000,000 JPY
409,925,000,000 JPY
254,420,000,000 JPY
Cash flows from (used in) investing activities
-172,890,000,000 JPY
-37,290,000,000 JPY
-44,926,000,000 JPY
Cash flows from (used in) financing activities
-69,469,000,000 JPY
-139,331,000,000 JPY
-69,647,000,000 JPY
Cash and cash equivalents
393,761,000,000 JPY
458,674,000,000 JPY
365,016,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.